|
Sign In to gain access to subscriptions and/or personal tools.
|
Review: Bariatric surgery: to treat diabesity
Peter R Flatt
School of Biomedical Sciences, University of Ulster, Coleraine, Northern Ireland, UK
Caroline Day
Diabetes Research Group, Aston University, Birmingham, UK
Clifford J Bailey
Diabetes Research Group, Aston University, Birmingham, UK, c.j.bailey{at}aston.ac.uk
In obese patients bariatric surgery is increasing in popularity as a strategy to promote, and maintain, weight loss. In obese type 2 diabetes bypass, bariatric surgery improves glycaemic control — often to a greater extent than would be anticipated by weight loss alone. Surgical bypass procedures appear to initially offer a greater glucose-lowering effect than surgical restriction procedures. This review considers the rationale for bariatric surgery as a treatment for diabesity and the implications of the different procedures on the secretion and action of enteral hormones.
Key Words: bariatric surgery GIP GLP-1 obesity type 2 diabetes
References
- Scheen AJ, Lefèbvre PJ Management of the obese diabetic patient. Diabetes Reviews 1999;7:77-93.[Web of Science]
- Henry RR, Gumbiner B. Benefits and limitations of very-low calorie diet therapy in obese NIDDM. Diabetes Care 1991;14:802-23.[Abstract]
- Wing RR, Koeske R., Epstein LH et al. Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med 1987;147:1749-53.[Abstract/Free Full Text]
- Kelley DE Effects of weight loss on glucose homeostasis in NIDDM. Diabetes Reviews 1995;3:366-77.
- Goldstein DJ Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord 1992;16:397-415.[Web of Science][Medline]
[Order article via Infotrieve]
- Pinkney J., Kerrigan D. When should bariatric surgery be used in the treatment of type 2 diabetes? Br J Diabetes Vasc Dis 2004;4:232-7.[Abstract/Free Full Text]
- Vetter ML, Cardillo S., Rickels MR, Iqbal N. Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med 2009;150:94-103.[Abstract/Free Full Text]
- Buchwald H., Avidor Y., Braunwald E. et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724-37.[Abstract/Free Full Text]
- Dixon JB, Pories WJ, O'Brien et al. Surgery as an effective early intervention for diabesity. Diabetes Care 2005;28:472-4.[Free Full Text]
- Herbst CA, Hughes TA, Gwynne JT, Buckwalter KA Gastric bariatric operation in insulin-treated adults. Surgery 1984;95:209-14.[Web of Science][Medline]
[Order article via Infotrieve]
- Pories WJ, MacDonald KG, Flickinger EG et al. Is type II diabetes mellitus (NIDDM) a surgical disease? Ann Surg 1992;215:633-43.[Web of Science][Medline]
[Order article via Infotrieve]
- Pories WJ, Swanson MS, MacDonald KG et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339-50.[Web of Science][Medline]
[Order article via Infotrieve]
- MacDonald KG, Long SD, Swanson MS et al. The gastric bypass operation reduces the progression and mortality on non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1997;1:213-20.[CrossRef][Medline]
[Order article via Infotrieve]
- Schauer PR, Burguera B., Ikramuddin S. et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003;238:467-85.[Web of Science][Medline]
[Order article via Infotrieve]
- Sugerman HJ, Wolfe LG, Sica DA, Clore JN Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003;237:751-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Scheen AJ Aggressive weight reduction treatment in the management of type 2 diabetes. Diabetes Metab 1998;23:116-23.
- Pontiroli AE, Pizzocri P., Librenti MC Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 2002;87:3555-61.[Abstract/Free Full Text]
- Sjostsrom L., Lindroos AK, Peltonen M. et al. Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-93.[Abstract/Free Full Text]
- Ponce J., Haynes B., Paynter S. et al. Effect of Lap-Band-induced weight loss on type 2 diabetes mellitus and hypertension. Obes Surg 2004;14:1335-42.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Dixon JB, O'Brien PE Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002;25:358-63.[Abstract/Free Full Text]
- Dixon JB, O'Brien PE, Playfair J. et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008;299:316-23.[Abstract/Free Full Text]
- Flatt PR, Bailey CJ, Green BD Recent advances in antidiabetic drug therapies targeting the enteroinsular axis. Curr Drug Metab 2009;10:125-37.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Flatt PR Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide (GIP): evidence and clinical opportunity for development of new obesity-diabetes drugs? Diabetes Vasc Dis Res 2007;4:151-3.
- Meier JJ, Nauck MA, Schmidt WE, Gallwitz B. Gastric inhibitory polypeptide: the neglected incretin revisited. Regul Pept 2002;107:1-13.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Bailey CJ, Wilkes LC, Conlon JM et al. Effects of gastric inhibitory polypeptide, vasoactivie intestinal polypeptide and peptide histidine isoleucine on the secretion of hormones by isolated mouse pancreatic islets. J Endocrinol 1990;125:375-9.[Abstract/Free Full Text]
- Gault VA, Irwin N., Green BD et al. Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro 3) GIP administration improves glucose tolerance and ameliorated insul-n resistance and abnormalities of islet struture in obesity-related diabetes. Diabetes 2005;54:2436-41.[Abstract/Free Full Text]
- Miyawaki K., Yamada Y., Ban et al. Inhibition of gastric inhibitory polypeptide signalling prevents obesity. Nat Med 2002;8:738-42.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Flatt PR Dorothy Hodgkin Lecture 2008. Gastric inhibitory polypeptide (GIP) revisited: a new therapeutic target for obesity-diabetes? Diabet Med 2008;25:759-64.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Murphy KG, Dhillo WS, Bloom SR Gut peptides in the regulation of food intake and energy homeostasis. Endrocr Rev 2006;27:719-27.[Abstract/Free Full Text]
- Clements RH, Gonzalez Q., Long CJ et al. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type 2 diabetes mellitus. Am Surg 2004;70:1-5.[Web of Science][Medline]
[Order article via Infotrieve]
The British Journal of Diabetes & Vascular Disease, Vol. 9, No. 3,
103-107 (2009)
DOI: 10.1177/1474651409103927

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|